Gemtuzumab ozogamicin
About
Therapy type: Immunotherapy
Therapy strategy: CD33 inhibition
Mappings
NCI Thesaurus: Gemtuzumab Ozogamicin (coding:ncit:C1806)
RxNorm: gemtuzumab ozogamicin (coding:rxcui:1294580, coding:omop:42799711)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (4) | CD33 + | Acute Lymphoblastic Leukemia | Gemtuzumab ozogamicin | |
| EMA (1) | CD33 + | Acute Myeloid Leukemia | Cytarabine, Daunorubicin, Gemtuzumab ozogamicin |